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Abstract Clinical initiatives have aimed to reduce the
age at ASD diagnosis in the UK. This study investigated
whether the median age at diagnosis in childhood has
reduced in recent years, and identified the factors associ-
ated with earlier diagnosis in the UK. Data on 2134 chil-
dren with ASD came from two large family databases.
Results showed that the age of ASD diagnosis has not
decreased. The median age of diagnosis of all ASDs was
55 months. Factors associated with earlier age of diagnosis
were autism diagnosis (compared with other ASD), lan-
guage regression, language delay, lower socioeconomic
status, and greater degree of support required. Effective
clinical strategies are needed to identify children with
characteristics that have in the past delayed ASD diagnosis.
Keywords Autism  Autism spectrum disorder  ASD 
Age at diagnosis
Introduction
There is a growing body of evidence to suggest that early
intervention programmes can improve overall functioning,
social communication, language, cognition and adaptive
behaviour in children with autism spectrum disorder (ASD)
(e.g. Magiati et al. 2014; Oono et al. 2013). As children get
older, treatments may be less effective (Harris and
Handleman 2000), highlighting the importance of early
ASD diagnosis leading to timely intervention. Whilst ASD
can reliably be diagnosed as early as 24 months (Steiner
et al. 2012; Johnson et al. 2007), population based studies
have found that the median age of diagnosis tends to be at
around school entry age (Shattuck et al. 2009). In the UK, a
number of clinical initiatives have aimed to improve ASD
diagnostic services for children. For example, after wide-
spread variation in clinical diagnostic services was found in
2001, the National Autism Plan for Children (NAP-C) was
published, providing clear and structured recommendations
around the identification, assessment, diagnosis and access
to early intervention for preschool and primary school age
children with an ASD (NAP-C 2003). Subsequently, Pal-
mer et al. (2011) surveyed 243 UK child development
teams regarding their diagnostic practices, and compared
responses with 2001 data. Positive developments included
an increase in the availability of multidisciplinary team
(MDT) professionals, increase in the number of teams with
a written ASD assessment protocol and increased use of
standardised diagnostic measures. However, only one-third
of teams had a defined timescale for completion of
assessment, and of those, only 49 % met the recommended
NAP-C timescale of completion of the process of assess-
ment and diagnosis in fewer than 30 weeks. In 2011, the
National Institute for Health Care Excellence (NICE)
published guidelines on the recognition, referral and
diagnosis of autism in children and young people from
birth to 19 years (NICE 2011).
Despite this focus on robust and improved diagnostic
assessment processes, there has been no up to date infor-
mation about whether the mean or median age at ASD
diagnosis of UK children has reduced. The most recent
population-based children’s UK study reported a median
age of diagnosis for all ASDs as 82 months (Williams et al.
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2008). In a survey of 1047 parents in the UK, Crane et al.
(2015) reported that the mean age of ASD diagnosis was
89 months; however 4 % of the children of these parents
were over 18 years old when they got their diagnosis, with
the maximum age being 40 years old. In the United States,
data from 1420 children with ASD revealed that the mean
age of diagnosis was 62.8 months (Oswald et al. 2015).
Centers for Disease Control and Prevention (CDC) data
from 2014 established that the median age of earliest
known ASD diagnosis was 53 months. In a recent review
of the current literature on age at diagnosis (42 UK and
non-UK studies), Daniels and Mandell (2013) reported
combined estimates of median age at diagnosis for all
ASDs to range from 36 to 82 months.
Researchers have previously highlighted that child,
family and environmental factors are associated with age at
diagnosis. For example, type of ASD diagnosis is made at
widely different ages. Williams et al. (2008) found the UK
median age of diagnosis of ‘autistic disorder’ to be
44.9 months, 115.9 months for Asperger syndrome, and
75.5 months for Pervasive Developmental Disorder—Not
Otherwise Specified/Autism Spectrum Disorder. Likewise,
Daniels and Mandell (2013) found that almost half of
studies reviewed reported a significantly later age of
diagnosis for Asperger syndrome, compared to all other
ASDs. Developmental regression has consistently been
associated with earlier diagnosis (Rosenberg et al. 2011;
Shattuck et al. 2009), as has having a sibling with ASD,
having lower level communicative function and higher
socioeconomic status (SES) (Valicenti-McDermott et al.
2012; Mandell et al. 2005; Fountain et al. 2011). However,
additional neurological and psychiatric comorbidities have
been shown to be associated with a later age at diagnosis
(Levy et al. 2010). There is contradictory evidence for the
role of other phenotypic factors in influencing age at
diagnosis. Studies have not consistently shown that learn-
ing/intellectual disability and sex are linked to earlier or
later diagnosis (Rosenberg et al. 2011; Shattuck et al. 2009;
Frenette et al. 2013; Wiggins et al. 2006; Coo et al. 2012).
Other factors such as ethnicity, maternal age, parental
concern, geographical location, and proximity to specialists
have all been reported as associated with age at diagnosis
(Daniels and Mandell 2013). However, due to differences
in study methodologies, inadequate study sizes and non-
representative sampling frames, there is wide variability in
findings associated with earlier or later diagnosis.
Recent multivariate analysis studies have examined
which combination of child, family and environmental
factors are the most strongly associated with the age at
ASD diagnosis in childhood. Bickel et al. (2015) observed
that significant predictors of earlier age at diagnosis were
later birth order, higher maternal education, fewer children
in the house, and a sibling with ASD. Furthermore, in their
sample of 315 children younger than 3 years, earlier
diagnosis was associated with higher cognitive and adap-
tive functioning, lower language level and having a sibling
with ASD. Mazurek et al. (2014) found that lower age,
higher SES, more severe autism symptoms and lower IQ
were associated with earlier age at diagnosis; however
higher functioning children were being diagnosed earlier
than in previous years.
This study aimed to (1) Explore whether the median age
at diagnosis in the UK has reduced in the last decade in a
large and representative sample of children with ASD; and
(2) Investigate the phenotypic factors associated with age
at diagnosis, to identify potential groups for whom clini-
cians might develop additional strategies to reduce the age
of diagnosis in the future.
Methods
The data were extracted from two large ASD family
research databases and included parent report of age of
diagnosis for 2134 children aged 2–18 years. The Database
of Children with ASD Living in the North East of England
(Daslne) covers six areas around Newcastle, whilst the
Autism Spectrum Database-UK (ASD-UK) covers the rest
of the geographical areas of the UK. Families join one
database or the other, based on their location.
Recruitment to Daslne
Daslne’s recruitment methods since 2003, and data about
the validity and representativeness of the ASD diagnoses of
included children, have been described previously
(McConachie et al. 2009; Wood et al. 2015; Warnell et al.
2015). In brief, families were recruited primarily through
community child health and mental health teams. Par-
ents/carers were invited to join Daslne shortly after their
child received an ASD diagnosis. Following informed
consent, parents completed a paper or online parent ques-
tionnaire (www.daslne.org/). The child’s diagnostic status
was validated by a questionnaire completed by their clin-
ician. Capture–recapture methods were used to ensure as
many local families as possible were approached about
Daslne. Validation of children’s ASD diagnoses was pre-
viously examined by selecting 40 children at random with
corroboration of diagnosis using standardised assessment
measures or clinical notes (McConachie et al. 2009).
Recruitment to ASD-UK
Following ethical and local approval, recruitment of fam-
ilies commenced in 2011 through a network of 72 ‘research
interested’ UK neurodisability, community child health and
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mental health teams. Families with one or more children,
aged 2–16 years, who had been given a clinical ASD
diagnosis, were eligible for recruitment. ASD-UK partici-
pation was discussed at a clinic appointment, or clinicians
wrote to families no longer reviewed in clinic. Families
received an information sheet and expression of interest
form; those who responded were telephoned by ASD-UK
staff to explain the project. A pack was then sent that
included a consent form, parent questionnaire and the
Social Communication Questionnaire—lifetime version
(Rutter et al. 2003). Alternatively, parents could register
and complete the consent and parent questionnaire online
(www.asd-uk.com). Families could also self-refer by con-
tacting ASD-UK directly or via the website. Families that
have joined ASD-UK are broadly representative of families
of children with ASD in the UK, and children included on
the databases have valid ASD diagnoses (Wood et al. 2015;
Warnell et al. 2015).
ASD-UK and Daslne share similar methodologies and
collect parallel data. Both ask parents questions about their
child with an ASD including their sex, type of ASD
diagnosis [autism, ASD (synonymous with Pervasive
Developmental Disorder-Not Otherwise Specified), and
Asperger syndrome], language, age at diagnosis (in
months), presence of a sibling with ASD, and presence of
an additional diagnosis (dyslexia, dyspraxia, ADHD,
learning/intellectual disability or ‘other’, in which parents
can describe the additional diagnosis). ASD-UK further
measures some variables historically associated with age at
diagnosis, including language regression (with or without
skill regression—referred to as ‘language regression’ from
here on) or skill regression (with or without language
regression—referred to as ‘skill regression’ from here on),
parent rating of level of support required, presence of a
relative with an ASD, and the presence of broader autism
phenotype (BAP) type traits in other family members,
categorised as having relatives with similar or milder
behaviours to those seen in ASD. ASD-UK also measures
SES by using the Townsend Index of Deprivation (Town-
send et al. 1988). This involves assigning a measure of
deprivation to families based on their postcode; the mea-
sure of deprivation for each postcode is based on unem-
ployment, non-car ownership, non-home ownership and
household overcrowding in that area.
Statistical Analysis
All data analyses were performed using SPSS 22.0. Median
age at diagnosis for children born in each calendar year was
calculated using descriptive statistics. To explore whether
there was a significant difference within categories of
factors associated with age at diagnosis, Mann–Whitney U
tests (for variables with two categories) or Kruskal–Wallis
tests (for variables with more than two categories) were
performed. Non-parametric tests were chosen as some of
the data were non-normally distributed. Hierarchical linear
regression was performed to determine variables that pre-
dicted age at diagnosis. Standardised regression coeffi-
cients are reported for linear regression analyses, with beta
values reporting the relative change between categories
within factors in age at diagnosis. For dummy coded
variables, this was the difference between each category
and the reference category. All other statistical analyses
were descriptive in nature, including the mean, SD, median
and interquartile range and number of children in the
analysis.
Results
Data from 2134 children and families were available (1164
from ASD-UK and 970 from Daslne). 82.7 % of the
included children were male, 17.3 % were female. The
median age at diagnosis was 55 months for all ASDs. Age
at diagnosis ranged from 7 to 223 months. Table 1 presents
data on the age of diagnosis given to children in the years
from 2004 to 2014. There was no significant difference in
age of diagnosis across these years (p = .504). There was
also no significant difference in the median age at diagnosis
for children diagnosed under age 36 months or under
60 months (see Fig. 1). Thus, there was no evidence of a
significant reduction in the UK mean or median age at ASD
diagnosis over the last decade.
Associations Between Age at Diagnosis, and Child
and Family Characteristics
Information on the number of children, their sex, diagnosis,
language ability, learning/intellectual disability, other
additional diagnoses, regression, support needed, and
presence of relatives with ASD and BAP are presented in
Table 2, and statistically significant results noted. The
variables for which there was no significant difference in
mean age of diagnosis were sex (p = .315), epilepsy
(p = .861), sibling with ASD (p = .976) and family
member with ASD (p = .307).
Children with additional diagnoses were diagnosed with
ASD later than children without other diagnoses
(p = .001). Specifically, children with ADHD (p\ .001),
dyslexia (p\ .001) and dyspraxia (p\ .001) were diag-
nosed much later than children who did not have these
conditions.
The effect of SES is presented in Table 3. The Town-
send deprivation score (higher score denotes more depri-
vation) was compared for children diagnosed before
36 months and those diagnosed from age 36 months
1976 J Autism Dev Disord (2016) 46:1974–1984
123
onward; a comparison was also made for children born
before 60 months, and those diagnosed from age
60 months onward. There was no significant difference in
the Townsend scores of children diagnosed before
36 months, and those diagnosed after this age; however,
when the threshold for diagnosis was increased to
60 months, children diagnosed before 60 months tended to
have a lower SES [a higher deprivation score (M = 1.22)]
than children diagnosed after 60 months (M = .32).
Regression Analyses
To further explore the predictive utility of the factors
associated with age of diagnosis, two hierarchical linear
regression analyses were carried out with age at diagnosis
as the dependent variable, and predictors chosen based on
significant difference in medians of subcategories, and
previous research (Table 2). Visual inspection of a
histogram of the residuals of the linear regression revealed
a normal distribution for both regression analyses.
In the first regression analysis, phenotypic characteris-
tics of children from both databases were included (2107
children). Sex was entered in Step 1. The dummy coded
ASD diagnoses variables (Autism, Asperger syndrome)
were entered at Step 2 (children with an ‘ASD’ diagnosis
were the reference category). Language delay was entered
in Step 3, with verbal children being the reference cate-
gory. This resulted in two dummy coded variables, echo-
ing/single words and non-verbal. Learning/intellectual
disability and other additional diagnoses were entered in
Step 4.
The first block, with sex as a predictor was significant,
F(1, 2105) = 4.67, p = .031, Radj
2 = .002 (Table 4).
Although a weak predictor, boys tended to have an earlier
age of diagnosis than girls (b = -.047). The second step of
the model was also significant, F(3, 2103) = 116.22,
Table 1 Median age of ASD diagnosis (in months) per year, and the number and proportion of children diagnosed under 36 months and under
60 months
Year N Mean SD Median Interquartile
range
N under
36 months
% diagnosed under
36 months
N under
60 months
% diagnosed under
60 months
2004 117 72.14 30.35 65.00 39.00 6 5.1 44 37.6
2005 104 63.67 34.38 55.00 53.00 23 22.1 56 53.8
2006 101 70.76 37.24 60.00 57.00 16 15.8 42 41.6
2007 108 68.37 35.86 57.00 54.00 12 10.5 56 49.1
2008 138 70.21 39.03 54.00 59.00 22 15.2 73 50.3
2009 147 70.05 40.15 61.00 43.00 21 13.7 70 45.8
2010 215 70.45 38.74 57.00 53.00 38 17.1 115 51.8
2011 290 72.24 39.35 61.00 56.00 38 12.8 140 47.1
2012 278 74.10 42.82 57.00 54.00 36 12.7 146 51.2
2013 247 74.53 41.15 60.00 54.00 28 11.1 121 48.0
2014 47 76.48 40.82 59.00 69.00 6 12.8 23 48.9
65
55
60
57
54
61
57
61
57
60 59
47
39 39.5 40 40 40.5
42 41 43 42 42
29.5 30 30 29 31 29 29.5 30
31.5 32 33.5
2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014
Total Median
Median age of children diagnosed under 5 years
Median age of children diagnosed under 3 years
Fig. 1 Median age at ASD
diagnosis (in months) from
2004 to 2014
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Table 2 Phenotypic factors and
their relation to age at diagnosis
(in months). Factors are grouped
according to whether they were
included in models 1 or 2 for the
regression analyses
N Percent Age of diagnosis Interquartile range Difference
Mean SD Median
Model 1 factors
Sex p = .315a
Male 1765 82.7 67.27 37.11 55.00 47.00
Female 369 17.3 72.05 42.97 55.00 60.00
Diagnosis p\ .001b
Combined 2134 100.00 68.10 38.22 55.00 48.00
Autism 459 21.61 47.98 28.06 40.00 22.00
ASD 1288 60.64 67.81 37.31 54.00 45.00
Asperger’s syndrome 377 17.75 93.38 36.82 87.00 56.00
Language p\ .001b
Verbal 1173 55.46 81.73 38.42 74.00 56.00
Echoing/single words 632 29.88 53.99 30.41 45.50 22.00
Non verbal 310 14.66 45.12 28.97 36.00 18.00
Learning/intellectual disability
Yes 737 34.54 61.14 37.23 48.00 37.00 p\ .001a
No 1397 65.46 71.77 38.24 60.00 54.00
Other additional diagnoses p = .001a
Yes 308 14.43 75.20 42.78 60.00 56.00
No 1826 85.57 66.90 37.27 54.00 48.00
Model 2 factors
Language regression p\ .001a
Yes 323 28.84 50.27 29.34 41.00 18.00
No 797 71.16 72.71 37.76 60.00 52.00
Skill regression p\ .001a
Yes 217 19.41 58.23 32.80 48.00 33.00
No 901 80.59 67.97 37.68 55.00 49.00
Level of support p\ .001b
Support 404 35.63 75.49 38.75 62.50 53.00
Substantial support 491 43.30 65.69 36.41 53.00 43.00
Very substantial support 239 21.07 52.98 31.73 43.00 25.00
Broader autism phenotype in relatives p\ .001a
Yes 646 57.32 70.05 38.60 58.00 52.00
No 481 42.68 61.40 34.91 48.00 40.00
Additional factors
Sibling with ASD
Yes 241 11.29 67.69 36.96 56.00 51.00 p = .976a
No 1893 88.71 68.15 38.38 55.00 48.00
Other family member with ASD
Yes 308 26.95 64.93 37.05 53.00 46.00 p = .307a
No 835 73.05 66.93 37.31 54.00 45.00
ADHD p\ .001a
Yes 287 13.45 78.17 36.45 72.00 47.00
No 1847 86.55 66.53 38.26 53.00 46.00
Dyslexia p\ .001a
Yes 56 2.62 98.02 42.29 104.00 68.00
No 2078 97.37 67.29 37.79 54.00 46.00
1978 J Autism Dev Disord (2016) 46:1974–1984
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p\ .001, Radj
2 = .141. The addition of type of ASD diag-
nosis accounted for a further 14.1 % of the variance in age
at diagnosis. Those with an autism diagnosis were diag-
nosed earlier than those with an ASD diagnosis
(b = -.216), while those diagnosed with Asperger syn-
drome were diagnosed later (b = .258). Language delay
was included in Step 3, which explained a further 8 % of
the variance in age at diagnosis, F(5, 2101) = 119.63,
Table 2 continued
N Percent Age of diagnosis Interquartile range Difference
Mean SD Median
Dyspraxia
Yes 199 9.33 91.55 42.45 88.00 66.00 p\ .001a
No 1935 90.67 65.68 36.93 53.00 45.00
Epilepsy
Yes 30 1.41 74.10 49.33 52.00 56.00 p = .861a
No 2104 98.59 68.01 38.04 55.00 48.00
a Mann Whitney U test, b Kruskal–Wallis test
Table 3 Socioeconomic status (Townsend index)
N Percent Mean SD Median Interquartile range Difference
36 month cut off
Diagnosed before 36 months 120 15.58 .94 4.61 -.83 6.32 p = .641a
Diagnosed aged 36 months or over 650 84.42 .80 4.17 -.67 4.99
60 month cut off p = .012a
Diagnosed before 60 months 431 55.97 1.22 4.49 -.386 5.70
Diagnosed aged 60 months or over 339 44.03 .32 3.86 -.089 4.08
a Mann Whitney U test
NB Townsend index positive values indicate more deprivation than the UK national average
Table 4 Results of the first
regression analysis (N = 2107)
Radj
2 B SE Beta t p
Step 1 .002
Sex -4.752 2.200 -.047 -2.160 .031
Step 2 .141
Sex -5.970 2.043 -.059 -2.922 .004
ASD (reference) versus autism -19.995 1.931 -.216 -10.356 .000
ASD (reference) versus Asperger 25.700 2.077 .258 12.371 .000
Step 3 .222
Sex -5.789 1.947 -.057 -2.973 .003
ASD versus autism -13.314 1.899 -.144 -7.012 .000
ASD versus Asperger 17.476 2.068 .175 8.450 .000
Verbal (reference) versus echoic -20.560 1.771 -.247 -11.606 .000
Verbal (reference) versus non verbal -28.205 2.282 -.261 -12.360 .000
Step 4 .225
Sex -5.426 1.945 -.054 -2.790 .005
ASD versus autism -13.313 1.898 -.144 -7.016 .000
ASD versus Asperger 17.083 2.084 .171 8.198 .000
Verbal versus echoic -20.577 1.779 -.247 -11.568 .000
Verbal versus non verbal -28.249 2.285 -.261 -12.360 .000
Learning/intellectual disability -.979 1.607 -.012 -.609 .542
Other additional diagnosis 8.574 2.080 .079 4.121 .000
Variance explained: 22.5 %
J Autism Dev Disord (2016) 46:1974–1984 1979
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p\ .001, Radj
2 = .222. Children whose language repertoire
included only single words or echoing were diagnosed
earlier than verbal children (b = -.247). Similarly non-
verbal children were diagnosed earlier than verbal children
(b = -.261). The final step of the model, including
learning/intellectual disability and additional diagnoses
was also significant, F(7, 2099) = 88.52, p\ .001
Radj
2 = .225. Whilst the inclusion of learning/intellectual
disability did not significantly add to the model
(b = -.012), the presence of another additional diagnosis
did (b = .079); those who had additional diagnoses
received their diagnosis of ASD later than those without.
The total model explained 22.5 % of the variance in age at
diagnosis.
The second regression analysis included data from
ASD-UK families only; the variables entered included all
the variables from regression 1 as well as the additional
variables measured by ASD-UK only. These included
language regression, skill regression, level of support
needed, and BAP in relatives, for which complete data
were available from 1041 participants. As in regression 1,
sex was entered in the first step, ASD diagnosis in Step 2,
language level in Step 3, and learning/intellectual disability
and additional diagnoses in Step 4. Parent reported lan-
guage regression and skill regression were entered in Step
5. Level of support needed was entered in Step 6 as dummy
coded variables, with ‘requires support’ as the reference
category. This resulted in two dummy coded variables
(‘requires substantial support’ and ‘requires very substan-
tial support’). Data about relatives with BAP were added in
Step 7 (Table 5).
The first block, with sex as a predictor was not signifi-
cant, F(1, 1039) = 1.718, p = .190, Radj
2 = .001. The
second step of the model was significant, F(3,
1037) = 59.83, p\ .001, Radj
2 = .145. The addition of
type of ASD diagnosis accounted for a further 14.4 % of
the variance in age at diagnosis. Those with an autism
diagnosis were diagnosed earlier than those with an ASD
diagnosis (b = -.145), while those diagnosed with
Asperger syndrome were diagnosed later (b = .324).
Language delay was included in Step 3, which explained a
further 8 % of the variance in age at diagnosis, F(5,
1035) = 161.37, p\ .001, Radj
2 = .225. Children whose
language repertoire included only single words or echoing
were diagnosed earlier than verbal children (b = -.239).
Similarly non-verbal children were diagnosed earlier than
verbal children (b = -.266). The next step of the model,
including learning/intellectual disability and additional
diagnoses was also significant, F(7, 1033) = 44.989,
p\ .001 Radj
2 = .228; although their addition explained a
further .3 % of the variance, neither learning/intellectual
disability nor additional diagnoses significantly added to
the model. Parent reported language regression and skill
regression were entered in the next step, which was sig-
nificant F(9, 1031) = 37.78, p\ .001 Radj
2 = .241,
explaining an additional 1.3 % of the variance. Children
with language regression were significantly more likely to
have an earlier age of diagnosis than those with no lan-
guage regression (b = -.126); there was no difference in
the age at diagnosis between children who had skill
regression and those who did not (b = -.004). The next
step including the level of support required by children was
also significant, F(11, 1029) = 31.39, p\ .001
Radj
2 = .243. Children whose parents reported needing
‘very substantial support’ received an earlier diagnosis
(b = -.070). Although the next step, including relatives
with BAP, was significant, F (12, 1028) = 28.78, p\ .001
Radj
2 = .243, it did not significantly add to the model. The
whole model accounted for 24.3 % of the variance in age
of ASD diagnosis.
Discussion
This study of over 2000 children shows that the median
age of ASD diagnosis in the UK has not reduced in the
last decade. The study also showed no evidence of
reduction in the age at diagnosis of children who
received their diagnosis below age 60 months, or age
36 months. The median age at ASD diagnosis in the
whole sample was 55 months, in line with figures re-
ported by the CDC in the US (2014), but much lower
than the 82 months reported by the UK study of 86
children (Williams et al. 2008), and the 66–71 months
reported in a previous UK study of 267 children (Latif
and Williams 2007).
In the context of increasing evidence that early inter-
vention is likely to improve some outcomes for children
and families, this finding has importance for parents and
clinicians, and may have significant health economic
implications, considering the costs associated with ASD
in the UK (Buescher et al. 2014). We do not have infor-
mation about why the age at ASD diagnosis has not
reduced in the last decade; however it is likely determined
by a combination of a number of systemic factors. As
reported by Palmer et al. (2011), in 2007 two-thirds of UK
child health ASD assessment teams did not have a defined
timescale for ASD assessment. Of the one-third that did,
almost half were not meeting targets set out by NAP-C
(2003). It is possible that early detection of ASD symp-
toms is occurring but that the complex pathway to getting
a diagnosis results in long delays between initial parental
concern, referral, assessment and diagnosis. There may be
parental delay in seeking a diagnosis; some parents may
notice atypical development early in their child’s life but
may wait to see if more developmental progress is made
1980 J Autism Dev Disord (2016) 46:1974–1984
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Table 5 Results of the second
regression analysis (N = 1041)
Radj
2 B SE Beta t p
Step 1 .001
Sex -3.786 2.889 -.041 -1.311 .190
Step 2 .145
Sex -4.207 2.673 -.045 -1.574 .116
ASD (reference) versus autism -13.440 2.727 -.145 -4.929 .000
ASD (reference) versus Asperger 32.357 2.937 .324 11.017 .000
Step 3 .225
Sex -4.382 2.546 -.047 -1.721 .085
ASD versus autism -7.748 2.655 -.083 -2.919 .004
ASD versus Asperger 24.397 2.917 .244 8.365 .000
Verbal (reference) versus echoic -18.701 2.351 -.239 -7.956 .000
Verbal (reference) versus non verbal -28.951 3.216 -.266 -9.003 .000
Step 4 .228
Sex -3.947 2.545 -.042 -1.551 .121
ASD versus autism -8.424 2.663 -.091 -3.164 .002
ASD versus Asperger 25.303 2.950 .253 8.577 .000
Verbal versus echoic -19.354 2.368 -.247 -8.172 .000
Verbal versus non verbal -29.353 3.215 -.270 -9.130 .000
Learning/intellectual disability 4.033 2.221 .052 1.816 .070
Other additional diagnoses 4.590 2.590 .048 1.772 .077
Step 5 .241
Sex -4.025 2.524 -.043 -1.595 .111
ASD versus autism -7.718 2.648 -.083 -2.915 .004
ASD versus Asperger 24.143 2.937 .241 8.220 .000
Verbal versus echoic -17.512 2.385 -.223 -7.342 .000
Verbal versus non verbal -26.241 3.267 -.241 -8.033 .000
Learning/intellectual disability 4.800 2.209 .062 2.173 .030
Other additional diagnoses 4.850 2.571 .051 1.886 .060
Language regression -10.256 2.452 -.126 -4.183 .000
Skill regression -.395 2.670 -.004 -.148 .882
Step 6 .243
Sex -4.239 2.524 -.045 -1.679 .093
ASD versus autism -6.666 2.694 -.072 -2.474 .014
ASD versus Asperger 23.956 2.942 .240 8.142 .000
Verbal versus echoic -16.942 2.413 -.216 -7.022 .000
Verbal versus non verbal -24.565 3.363 -.226 -7.303 .000
Learning/intellectual disability 5.515 2.237 .071 2.466 .014
Other additional diagnoses 5.416 2.591 .057 2.090 .037
Language regression -10.158 2.451 -.125 -4.144 .000
Skill regression .321 2.691 .003 .119 .905
Support (reference) versus substantial -1.671 2.354 -.023 -.710 .478
Support (reference) versus very substantial -6.299 3.093 -.070 -2.037 .042
Step 7 .243
Sex -4.276 2.525 -.046 -1.693 .091
ASD versus autism -6.704 2.695 -.072 -2.487 .013
ASD versus Asperger 24.115 2.951 .241 8.171 .000
Verbal versus echoic -17.177 2.436 -.219 -7.051 .000
Verbal versus non verbal -24.846 3.388 -.228 -7.334 .000
Learning/intellectual disability 5.410 2.242 .070 2.413 .016
Other additional diagnoses 5.599 2.604 .059 2.150 .032
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with time. Suboptimal awareness of the features of ASD
in family practitioners (health visitors and General Prac-
titioners) may also be a contributing factor, and lead to
parental reassurance where referral would be more
appropriate. This has been recognised as a problem by
organisations leading family care in the UK (The Royal
College of General Practitioners); ASD has recently been
adopted as a clinical priority for General Practitioners
(GPs) from 2014 until 2017 with the aim of improving the
training GPs receive in the recognition of ASD. Some of
these factors might explain the recent evidence from 1047
UK parents that the mean time interval from initial
expression of parental concern to a health professional
and ASD diagnosis was 3.6 years (Crane et al., 2015).
Increased publicity and awareness about ASD, and a
recognition of the broader autism spectrum, means some
children are being referred for assessment at school age;
indeed our sample included children who received a
diagnosis up to 18 years. Whilst the referral of older
children could have skewed the mean age at diagnosis, it
would have been unlikely to significantly alter the median
age and it would not explain the lack of reduction in age at
diagnosis for the children diagnosed at under age
36 months or under 60 months.
Considering the factors associated with age at ASD
diagnosis, male-sex, autism diagnosis, language regression,
language delay, higher levels of required support and lower
SES were associated with a younger age at diagnosis. The
presence of additional diagnoses was associated with a
later age at ASD diagnosis in our sample of 2107 families,
but when additional variables were included in the second
regression model with a smaller sample, additional diag-
noses were not found to be a significant predictor. Learn-
ing/intellectual disability did not affect age at diagnosis,
consistent with previous research (Fountain et al. 2011;
Frenette et al. 2013). This was the first study to include
having relatives with BAP as a possible predictor of age at
ASD diagnosis. It could be hypothesised that because other
family member display these ASD-like behaviours, the
manifestation of these in their own child would trigger
parental concern; however this variable did not signifi-
cantly predict age at diagnosis. Contrary to our hypothesis,
and previous research (for example, Coo et al. 2012),
having a sibling with ASD did not result in an earlier age at
diagnosis. There are several possible explanations for this.
When parents have one child with ASD, they may or may
not recognise ASD developmental signs in the second
child, as there are frequently differences in the develop-
mental presentation. For example, the first child may have
autism and language regression, whereas the sibling’s
language may have developed in line with age expectations
but social communication difficulties only become clearer
at school age. Parental concern expressed to professionals
is sometime dismissed by explanations of the second child
copying the behaviours of the first, or parents being overly
concerned due to having one child already on the spectrum.
Previous research has reported developmental regression as
being a marker for earlier diagnosis (Shattuck et al. 2009).
In this study parents reported whether their child had
regressed in language, and if they lost other skills. Only
language regression was predictive of age at diagnosis. The
fact that skill regression was not associated with an earlier
age at diagnosis may also be surprising. Previous research
has shown that language regression is rarely the only type
of regression; Parr et al. (2011) reported 11.4 % of children
who experienced regression had non-language regression.
It is likely there was variability in what parents viewed as
‘skill’ regression, and therefore it is difficult to draw con-
clusions from this finding.
Considering the number of studies linking higher SES to
an earlier age at diagnosis (for e.g. Goin-Kochel et al.
2006), it may seem surprising that in this study children
diagnosed before 60 months had lower SES than children
diagnosed after 60 months. However, there is universal
free healthcare access in the UK, which may lessen the
impact of SES on access to services in comparison with the
US and some other countries.
Our results should be seen in the context of what we
know about ‘red flags’ for autism (Wetherby et al. 2004),
that led to the US ALARM guidance for practitioners (Parr
and Woodbury-Smith 2015). In our study, children who
displayed language regression were diagnosed on average
at 3 years 5 months. The fact that regression most com-
monly occurs in the second year of life (Parr et al. 2011)
means that some children were not diagnosed with ASD for
almost 2 years after they lost previously acquired language
Table 5 continued
Radj
2 B SE Beta t p
Language regression -10.205 2.453 -.125 -4.160 .000
Skill regression .488 2.702 .005 .181 .857
Support versus substantial -1.698 2.355 -.023 -.721 .471
Support versus very substantial -6.478 3.104 -.072 -2.087 .037
Relatives similar difficulties -1.488 2.108 -.020 -.706 .480
Total variance explained: 24.3 %
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skills. Children who had only single word speech at diag-
nosis were diagnosed on average at 3 years 9 months. One
might expect children with language regression or lan-
guage delay to receive much earlier diagnoses than found
in this study. Children with additional diagnoses were not
diagnosed until 5 years, whilst children with ADHD were
not diagnosed until 6 years. Similarly, children presenting
with dyslexia or dyspraxia were diagnosed much later than
children who did not have these conditions. Diagnostic
overshadowing and the lack of recognition of ASD in the
presence of psychiatric and neurological disorders may
result in delayed intervention that might potentially ame-
liorate their disability and improve their outcomes (Joshi
et al. 2014).
Strengths of this study include the large sample size and
age range. Both databases are representative of the ASD
population in the UK, and ASD diagnostic validity has
been shown (Warnell et al. 2015); ASD diagnoses were
confirmed by medical reports supplied by parents. We also
analysed a large range of variables, including child, family
and environmental characteristics, using multiple regres-
sion models whereas previous studies have analysed pre-
dictors using odds ratios (e.g. Valicenti-McDermott et al.
2012). Limitations of this study include the exclusion of
some variables that have previously been linked to age at
diagnosis: child’s age at first parental concern, maternal
age, maternal education, previous relationship with ser-
vices; data on these aspects were not collected. Secondly,
our data are parent-reported and the detail not corroborated
by clinician report, and therefore possibly subject to recall
bias; however, this should be seen in the context of retro-
spective parent data being a valuable and reliable source of
information by clinicians evaluating child development in
health clinics.
Implications of this Research
The age at ASD diagnosis has not decreased in the UK in
recent years despite increased publicity, clinical initiatives
and awareness of ASD, and the knowledge that some
phenotypes are strongly associated with ASD. For children,
delayed diagnosis can result in lack of early intervention,
suboptimal school placement, and lack of access to the
strategies helpful for children with ASD. For parents,
delays in diagnosis mean they are missing out on under-
standing their child’s difficulties, and receiving the
appropriate support, help and management strategies they
need (NICE 2013; Myers and Johnson 2007). So what can
be done to reduce the age at ASD diagnosis? Children with
phenotypic characteristics that are ‘red flags’ for ASD such
as language regression and language delay could be iden-
tified through primary and other health service based
intervention initiatives to accelerate the ASD diagnostic
process. For children diagnosed at age 5 years or later, girls
receive their diagnosis at a later age than boys, and timely
diagnosis should be a focus for improvement in clinical
teams. Clear understanding of the reasons for the lag in
diagnosis in girls is a clear future research priority (Petrou
et al., manuscript in preparation). For children who do not
display these ‘red flags’, it is vital that we develop inno-
vative clinical research strategies to ensure children and
parents can access diagnostic assessment in a timely
fashion.
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